financetom
Business
financetom
/
Business
/
MP Materials posts smaller-than-expected loss on higher output, sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MP Materials posts smaller-than-expected loss on higher output, sales
Nov 9, 2024 1:05 PM

Nov 7 (Reuters) - U.S. rare earths miner and processor MP Materials Corp ( MP )

on Thursday reported a smaller-than-expected loss in the third quarter,

helped by higher production and sales volumes of the strategic materials.

MP produces rare earths concentrate at its mine in California which is sold

through a distributor to independent refineries globally including in China. It

is now increasing production of refined rare earths on-site in California and

commissioning metal production equipment at a new facility in Texas.

The company sold 9,729 metric tons of that concentrate during the quarter,

6% higher than the year-ago period.

The growth in sales was driven by higher production volumes, reflecting

higher mineral recoveries and operational efficiencies, the company said.

However, realized prices of rare earth concentrates declined 23% in the

quarter due to ongoing soft pricing environment for rare earth products.

MP Materials ( MP ) produced 478 tons of neodymium and praseodymium (NdPr) - the

two most in-demand rare earths - during the quarter, with 404 tons sold. Sales

nearly tripled sequentially.

"Despite continued weak market pricing, increased NdPr sales volumes drove a

return to year-over-year revenue growth," said CEO Jim Litinsky, who is also the

largest shareholder of the company with an 11.2% stake.

Cost of sales rose over 150% in the quarter, but were partially offset by a

reduction of an inventory reserve of $2.7 million recorded in the quarter.

Excluding one-time items, MP posted a loss of 12 cents per share, compared

with analysts' expectations of a loss of 13 cents per share, according to data

compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digital display maker Daktronics' Q1 revenue beats estimates, orders up 35%
Digital display maker Daktronics' Q1 revenue beats estimates, orders up 35%
Sep 10, 2025
Overview * Daktronics fiscal Q1 2026 revenue beats analyst expectations, driven by strong order growth * Net income for fiscal Q1 2026 improves significantly from prior year loss * Co repurchased shares, indicating confidence in financial position Outlook * Daktronics ( DAKT ) reiterates 7-10% sales growth over three years * Company aims for 10-12% operating margin in three-year plan...
Accenture, Google Collaborate to Boost Eneva's Operations
Accenture, Google Collaborate to Boost Eneva's Operations
Sep 10, 2025
08:14 AM EDT, 09/10/2025 (MT Newswires) -- Accenture ( ACN ) and Google ( GOOG ) said Wednesday that they are collaborating with Eneva, a Brazilian energy provider, to enhance the latter's operations using cloud, data and AI technologies. Accenture ( ACN ) said it migrated Eneva's Infrastructure to Google Cloud to improve access to data across the enterprise, including...
enCore Energy Gains on CFO Appointment
enCore Energy Gains on CFO Appointment
Sep 10, 2025
08:12 AM EDT, 09/10/2025 (MT Newswires) -- enCore Energy (EU.V) traded 2.2% higher at last look Wednesday in Nasdaq premarket trading after appointing Kevin Kremke as chief financial officer, effective Oct. 1. Kremke has held CFO roles in both publicly traded and private equity-backed companies, with experience in corporate finance, M&A, capital markets, and operations, the company said. His extensive...
BRIEF-LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
BRIEF-LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Sep 10, 2025
Sept 10 (Reuters) - LakeShore Biopharma Co Ltd ( LSB ): * LAKESHORE BIOPHARMA ANNOUNCES APPOINTMENT OF INDEPENDENT FINANCIAL ADVISOR AND LEGAL COUNSEL TO THE SPECIAL COMMITTEE * LAKESHORE BIOPHARMA CO LTD ( LSB ) - SPECIAL COMMITTEE CONTINUES REVIEW OF PROPOSAL Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved